长风药业股份有限公司（股票代码：02652）于2026年2月25日发布翌日披露报表，宣布通过香港联合交易所回购股份。根据公告，本次回购数量为33,000股，占回购前已发行股份约0.0109%。本次股份回购价格区间为每股36.64港元至37.9港元，合计支付1,232,250港元。
回购完成后，公司已发行股份数量变更为301,800,586股，库藏股数量增至423,000股，合计股份数保持在302,223,586股。公司于2025年12月16日通过该回购授权，可回购上限为30,222,358股，截至公告日已累计回购423,000股。
公告同时披露，公司已遵守香港联合交易所有限公司证券上市规则及其他相关法律法规的要求。本公告由执行董事及联席公司秘书朱玉玉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.